10/24/2012

Neuraxial analgesia is an effective palliative care option for cancer patients with refractory pain or opioid toxicity, and it can be continued after discharge, according to Dr. Aynharan Sinnarajah, an intensive palliative care physician from Alberta, Canada. He told a palliative care conference that fentanyl and methadone are commonly used instead of first-line opioids and that patients often are on their third or fourth opioid drug before neuraxial analgesia is considered.

Related Summaries